MustGrow Investor Webcast: Wednesday, March 2nd at 4:15pm ET
27 February 2022, Canada: MustGrow Biologics Corp., an agriculture biotechnology company focused on providing organic biological crop protection solutions, announces an investor
Read More
MustGrow
MustGrow Reports Successful Postharvest Applications in Stored Potatoes
Successful postharvest study in both Fusarium dry rot disease control and sprout suppression MustGrow’s mustard-based technology outperformed leading synthetic chemical standards No combination treatment products
Read More
MustGrow and Bayer sign Exclusive Agreement to develop sustainable organic biologicals in Europe, Asia Pacific, Middle East and Africa
22 January 2022, Canada: MustGrow Biologics Corp. and Bayerhave signed an Exclusive Agreement to evaluate MustGrow’s biological technologies to determine efficacy
Read More
MustGrow and Sumitomo Corporation Report Significant Program Expansion; Successful US Field Trials
Successful US field trials in cotton, soybeans and cucurbits MustGrow’s mustard-based technology showed efficacy comparable to synthetic chemical standards for
Read More
MustGrow Reports Successful Banana Field Trials in Colombia; Program Transitions to Sumitomo Corporation
Field data confirmed reduced incidence and severity of Fusarium wilt TR4 symptoms in banana plants after application of MustGrow’s product.
Read More
MustGrow Outlines Upcoming Investment Conferences
07 November 2021, Canada: MustGrow Biologics Corp. is pleased to announce its upcoming investor awareness initiatives. MustGrow continues to actively engage its
Read More
MustGrow Biologics Closes $7.1 Million Private Placement
10 October 2021, Canada: MustGrow Biologics Corp. is pleased to announce the closing of its previously-announced non-brokered private placement (the
Read More
MustGrow Biologics Upsizes Private Placement to $6.9 Million; Gluskin Invests $1 Million
29 September 2021, Canada: MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (“MustGrow”) is pleased to announce it has upsized its
Read More
MustGrow Biologics Arranges $2 Million Equity Private Placement
13 September 2021, Canada: MustGrow Biologics Corp. is pleased to announce a non-brokered private placement of approximately 770,000 units for gross
Read More
MustGrow Biologics and Sumitomo Corporation Announce Exclusive Agreement
04 August 2021, Canada: MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (“MustGrow”) and Sumitomo Corporation (TYO: 8053) (OTC: SSUMY) have signed an Exclusive
Read More